申请人:Koppitz Marcus
公开号:US20120128662A1
公开(公告)日:2012-05-24
The present invention relates to substituted imidazoquinoxaline compounds of general formula (I) as inhibitors of Mps-1 Kinase or TTK, and being active against inflammation and cancer.
本发明涉及通式(I)的取代
咪唑喹噁啉化合物,作为Mps-1激酶或
TTK的
抑制剂,并对炎症和癌症具有活性。